These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2179362)

  • 1. Low dose quinidine-mexiletine combination therapy versus quinidine monotherapy for treatment of ventricular arrhythmias.
    Giardina EG; Wechsler ME
    J Am Coll Cardiol; 1990 Apr; 15(5):1138-45. PubMed ID: 2179362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmias.
    Morganroth J
    Am J Cardiol; 1987 Dec; 60(16):1276-81. PubMed ID: 3318368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial.
    Singh JB; Rasul AM; Shah A; Adams E; Flessas A; Kocot SL
    Am J Cardiol; 1984 Jan; 53(1):84-7. PubMed ID: 6362388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mexiletine and quinidine in ventricular ectopy.
    Fenster PE; Hanson CD
    Clin Pharmacol Ther; 1983 Aug; 34(2):136-42. PubMed ID: 6347497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mexiletine-quinidine combination: electrophysiologic correlates of a favorable antiarrhythmic interaction in humans.
    Duff HJ; Mitchell LB; Manyari D; Wyse DG
    J Am Coll Cardiol; 1987 Nov; 10(5):1149-56. PubMed ID: 3668109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of oral quinidine-mexiletine combination therapy for sustained ventricular tachyarrhythmias as assessed by programmed electrical stimulation when quinidine monotherapy has failed.
    Bonavita GJ; Pires LA; Wagshal AB; Cuello C; Mittleman RS; Greene TO; Huang SK
    Am Heart J; 1994 Apr; 127(4 Pt 1):847-51. PubMed ID: 8154423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias.
    Kim SG; Mercando AD; Tam S; Fisher JD
    J Am Coll Cardiol; 1989 Mar; 13(3):659-64. PubMed ID: 2918173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral combination therapy with mexiletine and quinidine on left and right ventricular function.
    Sheldon RS; Duff HJ; Mitchell LB; Wyse DG; Manyari DE
    Am Heart J; 1988 May; 115(5):1030-6. PubMed ID: 3284310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mexiletine/quinidine combination therapy: electrophysiologic correlates of anti-arrhythmic efficacy.
    Duff HJ; Mitchell LB; Wyse DG; Gillis AM; Sheldon RS
    Clin Invest Med; 1991 Oct; 14(5):476-83. PubMed ID: 1660369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mexiletine versus quinidine as first-line antiarrhythmia therapy: results from consecutive trials.
    Frank MJ; Watkins LO; Prisant LM; Smith MS; Russell SL; Abdulla AM; Manwaring RL
    J Clin Pharmacol; 1991 Mar; 31(3):222-8. PubMed ID: 2019663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mexiletine. Long-term efficacy and side effects in patients with chronic drug-resistant potentially lethal ventricular arrhythmias.
    Kerin NZ; Aragon E; Marinescu G; Faitel K; Frumin H; Rubenfire M
    Arch Intern Med; 1990 Feb; 150(2):381-4. PubMed ID: 2302013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of mexiletine and quinidine in the treatment of ventricular ectopia.
    Assey ME; Hudson WM; Hanger KH; Miller SC
    South Med J; 1985 May; 78(5):565-8. PubMed ID: 2581322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mexiletine and propafenone: a comparative study of monotherapy, low, and full dose combination therapy.
    Takanaka C; Nonokawa M; Machii T; Lee S; Kato H; Haruna M; Yabe S
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2130-3. PubMed ID: 1279613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of tocainide and quinidine for better tolerance and additive effects in patients with coronary artery disease.
    Kim SG; Mercando AD; Fisher JD
    J Am Coll Cardiol; 1987 Jun; 9(6):1369-74. PubMed ID: 3108345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination antiarrhythmic treatment among class Ia, Ib, and II agents for ventricular arrhythmias.
    Tanabe T
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():827-34. PubMed ID: 1931759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.
    Duff HJ; Roden D; Primm RK; Oates JA; Woosley RL
    Circulation; 1983 May; 67(5):1124-8. PubMed ID: 6831673
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of oral mexiletine therapy in the treatment of ventricular arrhythmias.
    Rutledge JC; Harris F; Amsterdam EA
    J Am Coll Cardiol; 1985 Oct; 6(4):780-4. PubMed ID: 4031292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative cost-effectiveness analysis of quinidine, procainamide and mexiletine.
    Podrid PJ; Kowey PR; Frishman WH; Arnold RJ; Kaniecki DJ; Beck JR; Beshansky JR
    Am J Cardiol; 1991 Dec; 68(17):1662-7. PubMed ID: 1836102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.
    Tanabe T; Takahashi K; Yoshioka K; Goto Y
    Int J Cardiol; 1991 Sep; 32(3):303-12. PubMed ID: 1724233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with mexiletine and sotalol suppresses inherited ventricular arrhythmias in German shepherd dogs better than mexiletine or sotalol monotherapy: a randomized cross-over study.
    Gelzer AR; Kraus MS; Rishniw M; Hemsley SA; Moïse NS
    J Vet Cardiol; 2010 Aug; 12(2):93-106. PubMed ID: 20663731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.